David Greenberg has been appointed CEO of L’Oréal USA, President of North America Zone, and member of L’Oréal Executive Committee, effective immediately. David succeeds Stéphane Rinderknech, who has decided to continue his career outside of the Group.
Currently President of L’Oréal Professional Products Division in North America, David Greenberg has spent more than 28 years at L’Oréal in leadership roles across markets, divisions, brands and functions. “David most recently spearheaded the.
Sanofi: Annual General Meeting of April 30, 2021
30
Dividend of €3.20 per share payable as of May 7, 2021
Board composition: renewals, ratification of a co-opting Director and appointment of one new Director
Paris, France - April
1 - The Combined General Shareholders Meeting of Sanofi was held on April 30, 2021, without the physical presence of its shareholders, in accordance with the derogating measures adapting the rules governing the deliberation of general meetings taken by the French authorities as part of the fight against COVID-19, at the Company s registered office in Paris, under the chairmanship of Serge Weinberg. All resolutions submitted to the vote were adopted by the shareholders.
A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Sanofi
Sanofi’s Board of Directors proposes the appointment of Christian Brandts and Barbara Lavernos as Board Members
Sanofi’s Board of Directors proposes the appointment of Christian Brandts and Barbara Lavernos as Board Members
Sanofi’s Board of Directors proposes the appointment of Christian Brandts and Barbara Lavernos as Board Members
Paris, France – March 3, 2021 – At its meeting on March 3, 2021, Sanofi’s Board of Directors has decided to propose, on the occasion of its next General Shareholder Meeting to be held on April 30, 2021, the appointment of two new Directors, Christian Brandts and Barbara Lavernos, as well as the ratification of appointment by cooptation of Gilles Schnepp and the renewal of the mandates of Fabienne Lecorvaisier and Melanie Lee. Bernard Charlès, whose term of office will expire at the end of the next General Shareholder Meeting, did not wish to stand for re-election in order to avoid conflicts of interest that could arise from the de
Sanofi's Board of Directors proposes the appointment of Christian Brandts and Barbara Lavernos as Board Members Paris, France - March 3, 2021 - At its meeting on March 3, 2021, Sanofi's Board of Directors